• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童 感染多种治疗方案的比较:网状荟萃分析。

Comparison of multiple treatment regimens in children with infection: A network meta-analysis.

机构信息

Department of Pediatrics, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.

Jiangsu Key Laboratory of Pediatric Respiratory Disease, Institute of Pediatrics, Medical Metabolomics Center, Nanjing University of Chinese Medicine, Nanjing, China.

出版信息

Front Cell Infect Microbiol. 2023 Feb 23;13:1068809. doi: 10.3389/fcimb.2023.1068809. eCollection 2023.

DOI:10.3389/fcimb.2023.1068809
PMID:36909732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9995679/
Abstract

BACKGROUND

Multiple regimens have been widely used in the eradication treatment of infection in children. However, there is a lack of comparison and evaluation of their effectiveness in different regions of the world.

METHODS

Randomized controlled trials were retrieved. Review Manager 5.4, Stata SE 15 and R 4.0.4 statistical software were used to analyze date. The ranking probability is assessed according to the surfaces under cumulative ranking (SUCRA).

RESULTS

163 studies were eligible for this study, involving 336 arms and 18,257 children, and 10 different interventions. The results showed that the eradication rates of sequential therapy with probiotics (SP), bismuth-containing quadruple (Quadruple) therapy, concomitant therapy and PCN therapy were at least 90%. Cumulative ranking showed that SP therapy had the best eradication effect (SUCRA 92.7%) whereas Bismuth-containing triple therapy (B) had the worst (SUCRA 3.5%). Subgroup analysis suggested that SP therapy ranked first in China and other regions, and the ranking of Triple therapy with probiotics therapy (TP) was equally stable (SUCRA 72.0% 76.4% respectively). The security of the SP and TP therapy had great advantages.

CONCLUSIONS

As for the eradication treatment of infection in children, SP therapy ranks highest. SP and TP therapies are most safe.

摘要

背景

多种方案已广泛用于儿童感染的根除治疗。然而,缺乏对世界不同地区这些方案有效性的比较和评估。

方法

检索随机对照试验。使用 Review Manager 5.4、Stata SE 15 和 R 4.0.4 统计软件对数据进行分析。根据累积排序面(SUCRA)评估排序概率。

结果

共有 163 项研究符合纳入标准,涉及 336 个组和 18257 名儿童,10 种不同的干预措施。结果显示,益生菌序贯疗法(SP)、含铋四联疗法(Quadruple)、同时疗法和 PCN 疗法的根除率至少为 90%。累积排序显示 SP 疗法具有最佳的根除效果(SUCRA 92.7%),而含铋三联疗法(B)的效果最差(SUCRA 3.5%)。亚组分析表明,SP 疗法在中国和其他地区排名第一,益生菌三联疗法(TP)的排名同样稳定(SUCRA 分别为 72.0%和 76.4%)。SP 和 TP 疗法的安全性具有很大优势。

结论

对于儿童感染的根除治疗,SP 疗法排名最高。SP 和 TP 疗法最安全。

相似文献

1
Comparison of multiple treatment regimens in children with infection: A network meta-analysis.儿童 感染多种治疗方案的比较:网状荟萃分析。
Front Cell Infect Microbiol. 2023 Feb 23;13:1068809. doi: 10.3389/fcimb.2023.1068809. eCollection 2023.
2
The Efficacy and Safety of Regimens for Helicobacter pylori Eradication Treatment in China: A Systemic Review and Network Meta-Analysis.中国幽门螺杆菌根除治疗方案的疗效和安全性:系统评价和网络荟萃分析。
J Clin Gastroenterol. 2024 Jan 1;58(1):12-23. doi: 10.1097/MCG.0000000000001902.
3
Efficacy of second-line regimens for eradication treatment: a systemic review and network meta-analysis.二线方案在根治性治疗中的疗效:系统评价和网络荟萃分析。
BMJ Open Gastroenterol. 2020 Sep;7(1). doi: 10.1136/bmjgast-2020-000472.
4
Optimum duration of regimens for Helicobacter pylori eradication.幽门螺杆菌根除治疗方案的最佳疗程
Cochrane Database Syst Rev. 2013 Dec 11;2013(12):CD008337. doi: 10.1002/14651858.CD008337.pub2.
5
Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication.系统评价和网络荟萃分析:二线幽门螺杆菌根除治疗的疗效比较。
J Gastroenterol Hepatol. 2019 Jan;34(1):59-67. doi: 10.1111/jgh.14462. Epub 2018 Oct 11.
6
Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children.四种不同方案作为一线治疗方案根除幽门螺杆菌的比较:中国儿童的前瞻性、横断面、对照、开放试验。
Helicobacter. 2020 Apr;25(2):e12679. doi: 10.1111/hel.12679. Epub 2020 Jan 20.
7
Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis.多种不同一线治疗方案治疗幽门螺杆菌感染的疗效比较:一项网状 Meta 分析。
Gastroenterology. 2021 Aug;161(2):495-507.e4. doi: 10.1053/j.gastro.2021.04.012. Epub 2021 Apr 8.
8
Guideline-based bismuth quadruple therapy for helicobacter pylori infection in China: A systematic review and network meta-analysis.中国基于指南的铋剂四联疗法治疗幽门螺杆菌感染:一项系统评价和网络荟萃分析
PLoS One. 2025 Feb 20;20(2):e0318937. doi: 10.1371/journal.pone.0318937. eCollection 2025.
9
Efficacy and safety of Vonoprazan-based treatment of Helicobacter pylori infection: a systematic review and network meta-analysis.基于 Vonoprazan 的幽门螺杆菌感染治疗的疗效和安全性:系统评价和网络荟萃分析。
BMC Infect Dis. 2024 Sep 11;24(1):953. doi: 10.1186/s12879-024-09885-x.
10
A randomised controlled clinical study of standard triple therapy, bismuth-based quadruple therapy and sequential therapy for Helicobacter pylori infection in children.儿童幽门螺杆菌感染的标准三联疗法、铋四联疗法和序贯疗法的随机对照临床研究。
BMC Pediatr. 2024 Aug 23;24(1):543. doi: 10.1186/s12887-024-05020-6.

引用本文的文献

1
and the Human Gastrointestinal Microbiota: A Multifaceted Relationship.以及人类胃肠道微生物群:一种多方面的关系。
Antibiotics (Basel). 2024 Jun 24;13(7):584. doi: 10.3390/antibiotics13070584.
2
The Role of Probiotics in the Eradication of Helicobacter pylori and Overall Impact on Management of Peptic Ulcer: A Study Involving Patients Undergoing Triple Therapy in Bangladesh.益生菌在根除幽门螺杆菌中的作用及对消化性溃疡治疗的总体影响:一项针对孟加拉国接受三联疗法患者的研究
Cureus. 2024 Mar 16;16(3):e56283. doi: 10.7759/cureus.56283. eCollection 2024 Mar.

本文引用的文献

1
Are pro- and/or synbiotics beneficial in Helicobacter pylori eradication therapy in children? A narrative review.益生菌和/或合生元对儿童幽门螺杆菌根除治疗有益吗?一项叙述性综述。
Eur J Pediatr. 2022 Sep;181(9):3225-3234. doi: 10.1007/s00431-022-04523-7. Epub 2022 Jun 21.
2
A cross-sectional study on the association between Helicobacter pylori infection and headache.一项关于幽门螺杆菌感染与头痛之间关联的横断面研究。
Neurol Sci. 2022 Oct;43(10):6031-6038. doi: 10.1007/s10072-022-06153-1. Epub 2022 May 28.
3
Antibiotic resistance of Helicobacter pylori isolated from children in Chongqing, China.
中国重庆儿童分离的幽门螺杆菌的抗生素耐药性。
Eur J Pediatr. 2022 Jul;181(7):2715-2722. doi: 10.1007/s00431-022-04456-1. Epub 2022 Apr 25.
4
Use of DSM 17938 in paediatric gastrointestinal disorders: an updated review.DSM-17938 在儿科胃肠疾病中的应用:最新综述。
Benef Microbes. 2022 Aug 3;13(3):221-242. doi: 10.3920/BM2021.0151. Epub 2022 Feb 25.
5
The recurrence rate of Helicobacter pylori in recent 10 years: A systematic review and meta-analysis.近 10 年来幽门螺杆菌的复发率:系统评价和荟萃分析。
Helicobacter. 2021 Dec;26(6):e12852. doi: 10.1111/hel.12852. Epub 2021 Sep 12.
6
The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.《儿童幽门螺杆菌感染管理的 JSPGHAN 指南更新版》。
Pediatr Int. 2020 Dec;62(12):1315-1331. doi: 10.1111/ped.14388.
7
Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.《可信系统评价的更新指南:干预措施系统评价的新版Cochrane手册》
Cochrane Database Syst Rev. 2019 Oct 3;10(10):ED000142. doi: 10.1002/14651858.ED000142.
8
Efficacy of Lactobacillus-supplemented triple therapy for Helicobacter pylori infection in children: a meta-analysis of randomized controlled trials.补充乳酸杆菌的三联疗法治疗儿童幽门螺杆菌感染的疗效:一项随机对照试验的荟萃分析。
Eur J Pediatr. 2019 Jan;178(1):7-16. doi: 10.1007/s00431-018-3282-z. Epub 2018 Nov 16.
9
Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI.质子泵抑制剂的相对效力、幽门螺杆菌治疗的治愈率以及双倍剂量 PPI 的意义。
Helicobacter. 2019 Feb;24(1):e12554. doi: 10.1111/hel.12554. Epub 2018 Nov 15.
10
Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication.系统评价和网络荟萃分析:二线幽门螺杆菌根除治疗的疗效比较。
J Gastroenterol Hepatol. 2019 Jan;34(1):59-67. doi: 10.1111/jgh.14462. Epub 2018 Oct 11.